Back to search

Article

Synergistic Effects of Cepharanthine and Amphotericin B Against Candida albicans by Targeting PMP3-Mediated Sphingolipid Biosynthesis and Membrane Disruption

2026-05-26

Abstract excerpt

<title>Abstract</title> <p> Oral candidiasis, primarily caused by <italic>Candida albicans</italic> , poses challenges in current antifungal therapy because of limited number of drugs, increased pathogen resistance, and notable toxicity associated with existing medications. Combination therapy is crucial for optimizing treatment outcomes. In this study, cepharanthine (CEP) was explored as an adjunct to amphote...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2deefd55-fe3c-533a-a93a-cb8d871620df
DOI
10.21203/rs.3.rs-9714769/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Synergistic Effects of Cepharanthine and Amphotericin B Against Candida albicans by Targeting PMP3-Mediated Sphingolipid Biosynthesis and Membrane DisruptionDOI 10.21203/rs.3.rs-9714769/v1
Select a neighboring publication to make it the new centre.